Loading...
Validation of the VE1 Immunostain for the BRAF V600E Mutation in Melanoma
BACKGROUND: BRAF mutation status, and therefore eligibility for BRAF inhibitors, is currently determined by sequencing methods. We assessed the validity of VE1, a monoclonal antibody against the BRAF V600E mutant protein, in the detection of mutant BRAF V600E melanomas as classified by DNA pyroseque...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4167935/ https://ncbi.nlm.nih.gov/pubmed/24917033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cup.12364 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|